Affiliated Sites
  • Clinicians Network Payer Bioinformatics
Be The Match

Javascript disabled. This site requires JavaScript How to enable JavaScript.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close

NMDP

Be The Match
  • About Us
  • E-News Sign Up
  • My Cart
  • Transplant Indications and Outcomes
    • HLA Today
      • HLA Today
    • Disease-Specific Indications and Outcomes
      • AML - Adult
      • AML - Pediatric
      • ALL - Adult
      • ALL - Pediatric
      • MDS
      • CML
      • CLL
      • NHL
      • Hodgkin Lymphoma
      • Multiple Myeloma
      • Severe Aplastic Anemia & Marrow Failure
      • Sickle Cell Disease
      • Immune Deficiency Diseases
      • Inherited Metabolic Disorders
      • Thalassemia
      • Other Diseases
      • Multiple Sclerosis
      • Systemic Sclerosis
    • Additional Outcomes
      • Unrelated vs. Sibling Donor Outcomes
      • Older Patient Outcomes
      • Timing Impact on Outcomes
    • Eligibility
    • Referral Timing Guidelines
    • Order Kits
    • HLA Typing for Family Members
  • Transplant Therapy and Donor Matching
    • Cell Sources
    • HLA Typing and Matching
    • Donor or Cord Blood Search Process
      • Likelihood of Finding a Match
      • Preliminary Search Request
    • Jason Carter Clinical Trials Program
  • Post-Transplant Care
    • Early Complications
    • Vaccinations
    • Long-Term Care Guidelines
      • Pediatric Considerations
    • Chronic GVHD
      • Skin
      • Nails
      • Scalp and Body Hair
      • Eyes
      • Mouth
      • Lungs
      • Muscles, Fascia, Joints
      • Hematopoietic & Immune
      • GI Tract
      • Liver
      • Genitalia
      • Other
    • Post-Transplant Guidelines
  • Medical Education & Research
    • Browse News
    • Browse Research
      • Mismatched donor sources may fill an unmet need for patients without fully matched family or unrelated donors
      • Hematopoietic cell donor type may not impact quality of life post-transplant
      • Novel three-drug combination improves GVHD-free and relapse-free survival and relapse after allogeneic transplant
      • Long-term risks of hematological malignancy, autoimmune or thrombotic events do not differ in bone marrow and filgrastim-mobilized PBSC donors
      • Socioeconomic status but not race and ethnicity is likely associated with chronic GVHD outcomes after allogeneic HCT
      • Linkage across research databases may provide a more complete understanding of HCT patient outcomes
      • Race and ethnicity matching may not impact umbilical cord blood transplant patient outcomes
    • Education Catalog
    • Materials Catalog
    • HCT Presentation Slides
    • About Our Research
    • Transplant Enews
  • Resources
    • Patient Resources
    • Financial Resources
    • Obstetrician Resources
    • Technique Videos
    • Umbilical Cord Blood Collection Training for Public Donation

  • Email
  • Print This Page

Related Resources

  • HCT Indications and Outcomes
  • Disease-Specific Education Materials
  • Recent Research by Disease

Patient Resources

  • Patient Education Materials

Disease-Specific Hematopoietic Cell Transplant Education

Stay-up-to date on the latest research and care of patients with diseases that are treatable with hematopoietic cell transplantation (HCT).


View our new online education catalog for a complete list of courses and CME activities.

 

 

    On-Demand CME Activities

    Acute Myeloid Leukemia

    • Making AML therapy decisions at first remission: Is timing everything?
    • AML in older adults: Are outcomes age dependent?
    • AML risk stratification: Influence of emerging cytogenetics and molecular markers on treatment decisions

      On-Demand CNE Activities

        Acute Myeloid Leukemia and Myelodysplastic Syndromes

        • AML: Treatment Options, including BMT, Care and Support

        On-Demand Activities


        Acute Myeloid Leukemia and Myelodysplastic Syndromes

        • Podcast: Clinical Decisions in AML, featuring Linda J. Burns, M.D.

              • Email
              • Print This Page

              Slides may be downloaded and used without permission for one-time presentation or personal use.  For publication, use in print or web, or repeated presentations, please submit a Copyright Request Form.

              Transplant Indications and Outcomes

              • HLA Today
              • Disease-Specific Indications and Outcomes
              • Additional Outcomes
              • Eligibility
              • Referral Timing Guidelines
              • Order Kits
              • HLA Typing for Family Members

              Transplant Therapy and Donor Matching

              • Cell Sources
              • HLA Typing and Matching
              • Donor or Cord Blood Search Process
              • Jason Carter Clinical Trials Program

              Resources

              • Patient Resources
              • Financial Resources
              • Obstetrician Resources
              • Technique Videos
              • Umbilical Cord Blood Collection Training for Public Donation

              Contact Us

              About Us

              Our Websites

              bethematch.org
              BeTheMatch.org Information and support for patients, donors and supporters of our mission.
              BeTheMatchBioTherapies.com
              BeTheMatchBioTherapies.com Proven solutions for organizations developing and delivering new cellular therapies
              CIBMTR.org
              CIBMTR.org Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.
              National Marrow Donor Program —
              Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including Be The Match Registry®.
              Copyright © 1996-2023 National Marrow Donor Program. All Rights Reserved. Terms of Use | Privacy Policy | Trademark & Copyright